The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•6 May 2026•

1 min read

Mixed US Q1 2026 Earnings as Companies Update Guidance and Expand Pipelines

Key Facts

1Marriott International reported a 4.2% global RevPAR increase and reached a record development pipeline of over 4,100 properties.

2Royalty Pharma raised its full-year 2026 guidance following a 10% growth in portfolio receipts to $925 million.

The Q1 2026 earnings season in the United States has revealed a diverse performance landscape across the hospitality, healthcare, and utilities sectors. Marriott International reported a 4.2% global RevPAR increase, bolstered by a record development pipeline of over 4,100 properties. In the healthcare space, Royalty Pharma raised its full-year guidance following a robust 10% growth in portfolio receipts to $925 million. Meanwhile, Spire Inc finalized its acquisition of Piedmont Natural Gas’s Tennessee operations and updated its adjusted earnings outlook. However, the broader sentiment remains balanced as companies like Bio-Techne and Bruker navigate revenue declines and macroeconomic headwinds. These updates highlight a strategic focus on expansion and guidance adjustments amidst shifting market conditions.